Nov 10, 2025 7:00 PM Eastern Standard Time Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR Share EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX) ("Surmodics†or the "Company†), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District Court for the Northern District of Illinois (the "District Court†) has denied a request ...

公司动态 - 公司于11月3日在拉斯维加斯举行的第23届VIVA年度会议上公布了PROWL注册研究结果 [1] - 研究分析基于160名患有症状性腹股沟下肢体缺血的真实世界患者数据 [1] - 研究结果在一个行业赞助的环节中进行展示 [1] 行业活动 - 第23届VIVA年度会议是医疗行业的重要会议 [1] - 行业赞助的会议环节是展示最新临床研究成果的平台 [1]

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr. Peter Monteleone, will present and discuss updated safety and performance data from the PROWL registry on 160 patients with symptomatic lower extremity (infrainguinal) vessels treated with the Pounceâ"¢ Thrombectomy Platform. The presentation will be held on Mon. ...